Explore how parenteral manufacturing solutions are evolving for specific drug formulations and meeting the demands of ...
Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to significantly reduce the complexities involved in setting up domestic manufacturing ...
With the FDA tightening its guidance around the production of nonbacterial beta-lactam drugs, Swedish CDMO Recipharm is touting new efforts to stay in compliance—and a new partnership. Juggling a mix ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines. Dr. Reddy’s, an Indian generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results